Earnings Poll: Swedish Orphan Biovitrum fourth quarter results due on February 5
Feb 4 (Reuters) - (All figures in Swedish Crowns)
* Swedish Orphan Biovitrum AB (publ) SOBIV.ST reports
its fourth
quarter results on February 5.
* Year to date, Swedish Orphan Biovitrum AB (publ) shares
are up
5.80%.
* Below is a table of quarterly and annual analyst estimates
for
results based on LSEG data.
Qtr. to No. of Mean
December analysts Estimate
2024
Revenue 7 7.38
billion
Pre-tax 4 1.47
profit billion
EPS 4 3.51
EBITDA 4 2.62
billion
EBIT 6 1.84
billion
Net Profit 5 1.20
billion
Year to No. of Mean
December Analysts Estimate
2024
Revenue 13 25.87
billion
Pre-tax
profit 8 4.42 billion
EPS
11 10.97
EBITDA
12 9.48 billion
EBIT
10 5.81 billion
Net Profit 10 3.73 billion
Dividend 9 0.00
Net Debt 7 13.77
billion
Swedish Orphan Biovitrum AB (publ) belongs to the OMX
Stockholm_PI. Please note that consensus estimates may be
updated between publication of the poll and the report.
This summary was auto generated on February 3 at 07:17.
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Swedish Orphan Biovitrum AB (publ)
See all newsTop of the Street: SOBI, Sonova, BAT, Imperial Brands
SOBI slips after Ionis lowers Tryngolza sales forecast
Brief: Swedish Orphan Biovitrum Executive Sells, Buys Shares
Europe Research Roundup: Centrica, Fuchs, URW
Brief: Swedish Orphan Biovitrum Proposes Börje Ekholm As New Chair And Board Member At 2027 AGM